Dr. Werner Lanthaler, chief executive officer of Evotec will resume his role following a period of leave due to health reasons. Dr. Flemming Ornskov, chairman of the supervisory board of Evotec, said, "The board is delighted to welcome back Dr. Lanthaler to resume his leadership of Evotec and to continue to drive the growth of the Company through Action Plan 2016. The board would also like to thank the management team of Colin Bond, Dr. Cord Dohrmann and Dr. Mario Polywka for managing the company in Dr. Lanthaler's absence."